{"id":"W4200122615","doi":"10.1016/j.annonc.2021.10.132","title":"114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Chemotherapy; Oncology; Lung cancer; Internal medicine; Phases of clinical research; Stage (stratigraphy); Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001254522,0.001486314,0.0020657,0.0006965339,0.0005420935,0.00144896,0.001793168,0.001906181,0.008716385],"category_scores_gemma":[0.0007328053,0.0007465705,0.001686794,0.0005028048,0.0008636683,0.001005594,0.0005031257,0.005820453,0.002549783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008314878,"about_ca_system_score_gemma":0.001772447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001830747,"about_ca_topic_score_gemma":0.004082572,"domain_scores_codex":[0.9996545,0.000139864,0.00001673186,0.00005666163,0.00003273247,0.00009952121],"domain_scores_gemma":[0.9994555,0.00006951128,0.0000621232,0.0000455757,0.00002977408,0.0003375192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6527785,0.10086,0.004561885,0.001684212,0.002549234,0.0003495029,0.0002727841,0.002911153,0.05491713,0.0006590564,0.0107311,0.1677254],"study_design_scores_gemma":[0.6033191,0.3791079,0.006797519,0.00005967145,0.0007897707,0.0002080191,0.00005424294,0.0009273397,0.004477331,0.0001423613,0.004079245,0.00003751802],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806449,0.004396026,0.0007898236,0.001037174,0.000520291,0.003714588,0.003086517,0.0003369417,0.005473675],"genre_scores_gemma":[0.9707878,0.00516945,0.003413923,0.001735251,0.0004066783,0.003152695,0.006083944,0.00008868201,0.009161596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008716385,"threshold_uncertainty_score":0.02915919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1475345320760051,"score_gpt":0.4615941176671869,"score_spread":0.3140595855911819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}